We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
-17.67%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$48.8B
AUM Growth
-$6.15B
Cap. Flow
+$12.8B
Cap. Flow %
26.19%
Top 10 Hldgs %
20.68%
Holding
4,585
New
132
Increased
2,502
Reduced
1,291
Closed
257

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$115M
2
IYF icon
iShares US Financials ETF
IYF
+$109M
3
V icon
Visa
V
+$108M
4
CHTR icon
Charter Communications
CHTR
+$73.8M
5
HON icon
Honeywell
HON
+$58.5M

Sector Composition

Rank Sector Weight
1 Technology 10.66%
2 Healthcare 6.66%
3 Financials 5.71%
4 Consumer Discretionary 5.02%
5 Communication Services 4.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NYMX
4001
DELISTED
Nymox Pharmaceutical Corp
NYMX
$433 ﹤0.01%
185
BFX
4002
DELISTED
BowFlex Inc.
BFX
$431 ﹤0.01%
165
CRD.B icon
4003
Crawford & Co Class B
CRD.B
$577M
$415 ﹤0.01%
65
FBIO icon
4004
Fortress Biotech
FBIO
$96.3M
$382 ﹤0.01%
13
FENC icon
4005
Fennec Pharmaceuticals
FENC
$419M
$368 ﹤0.01%
62
ACMR icon
4006
ACM Research
ACMR
$5.75B
$355 ﹤0.01%
36
FSFG
4007
DELISTED
First Savings Financial Group
FSFG
$351 ﹤0.01%
27
MGI
4008
DELISTED
MoneyGram International, Inc. New
MGI
$333 ﹤0.01%
254
MNTX
4009
DELISTED
Manitex International, Inc.
MNTX
$318 ﹤0.01%
77
AE
4010
DELISTED
Adams Resources & Energy Inc
AE
$306 ﹤0.01%
13
BH.A icon
4011
Biglari Holdings Class A
BH.A
$1.24B
$297 ﹤0.01%
1
TRAK icon
4012
ReposiTrak
TRAK
$151M
$285 ﹤0.01%
75
AMPE
4013
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$285 ﹤0.01%
2
GYRE icon
4014
Gyre Therapeutics
GYRE
$716M
$275 ﹤0.01%
8
KINS icon
4015
Kingstone Companies
KINS
$287M
$266 ﹤0.01%
52
SCPH
4016
DELISTED
scPharmaceuticals
SCPH
$266 ﹤0.01%
36
TBCH
4017
Turtle Beach Corp
TBCH
$235M
$262 ﹤0.01%
42
-190
-82% -$1.35K
SUP
4018
DELISTED
Superior Industries International
SUP
$257 ﹤0.01%
214
CTIC
4019
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$250 ﹤0.01%
272
PFSW
4020
DELISTED
PFSweb, Inc.
PFSW
$246 ﹤0.01%
82
IWP icon
4021
iShares Russell Mid-Cap Growth ETF
IWP
$21.1B
$243 ﹤0.01%
4
IBRX icon
4022
ImmunityBio
IBRX
$8.31B
$242 ﹤0.01%
84
-151
-64% -$756
KA
4023
DELISTED
Kineta, Inc. Common Stock
KA
$242 ﹤0.01%
2
PLYA
4024
DELISTED
Playa Hotels & Resorts
PLYA
$226 ﹤0.01%
129
-114
-47% -$655
EMKR
4025
DELISTED
Emcore Corp
EMKR
$215 ﹤0.01%
10

Similar funds

BNP Paribas Financial Markets's Q1 2020 Portfolio in Review

As of Q1 2020, BNP Paribas Financial Markets held 4,585 positions worth $48.8B, down 11% from $54.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

BNP Paribas Financial Markets deployed $12.8B of net new capital in Q1 2020, opening 132 new positions and adding to 2,502 existing holdings. Its largest new stake was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Pfizer, an estimated $115M trimmed.

  • BNP Paribas Financial Markets's largest Q1 2020 buy was iShares 0-1 Year Treasury Bond ETF: 132,067 shares worth $14.7M.
  • BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q1 2020, an estimated $2.91B increase.
  • BNP Paribas Financial Markets's biggest Q1 2020 reduction was Pfizer, cutting an estimated $115M.
  • BNP Paribas Financial Markets fully exited State Street SPDR S&P Health Care Equipment ETF in Q1 2020, selling an estimated $47.1M.
  • BNP Paribas Financial Markets's ten largest holdings make up 21% of its $48.8B portfolio in Q1 2020.
  • BNP Paribas Financial Markets opened 132 new positions and closed 257 in Q1 2020.
  • BNP Paribas Financial Markets's portfolio value fell 11% quarter-over-quarter to $48.8B.

Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.